Capital + Growth Keensight is a leading European Growth Buyout firm with over €8bn AUM and a focus on profitable growth for mid-market companies in Tech and Healthcare. This positions them as a potential co-investor or strategic buyer for growth-stage vendors, portfolio companies seeking liquidity, or PE-backed entities requiring scale investments.

Geographic Reach Active across Europe with additional presence in Paris, London, Boston and Singapore, and operations in over 90 countries. This global footprint offers opportunities for cross-border funding, market expansion support, and introductions to international acquirers or clients.

Portfolio Momentum Recent high-profile acquisitions in AI data automation, governance software, orthobiologics, and breath analysis devices indicate ongoing appetite for strategic platform plays and add-ons in technology, life sciences and healthcare tech. Target companies with differentiated IP or data-driven solutions could attract interest for growth equity or bolt-on acquisitions.

Leadership Expansion New appointments of managing directors, partners and HR leadership show active capability-building and governance development. This signals potential for expanding relationship management, interim leadership engagements, and advisory services for portfolio companies undergoing scaling and performance improvement initiatives.

Financial Profile Revenue in the $10M-$25M range with a large AUM base suggests Keensight is positioned to consider mid-market growth investments and scalable deals. Sales opportunities include co-investment opportunities, debt-financing collaborations, and co-sponsorship of growth rounds for revenue-rich tech and healthcare startups seeking strategic PE backing.